Skip to main contentSkip to navigation
Sirius Investors

MedTech Acquisition Corporation (MTAC) Financial Metrics

This dashboard provides comprehensive financial metrics and analysis to help evaluate MedTech Acquisition Corporation's investment potential. View key valuation ratios, profitability metrics, growth indicators, and historical trends to make informed investment decisions.

Financial Metrics Score

Valuation Metrics

Sector benchmarks: Industrials

2025
P/E Ratio
-3.79
Burn Risk
P/B Ratio
-10.14
Equity Deficit
Earnings Yield
-11.42%
Yield Gap

Profitability Health

2025
Return on Equity
115.85%
Strong
WeakModerateStrong
Operating Margin
-59.68%
Weak
WeakModerateStrong
Net Profit Margin
-86.88%
Weak
WeakModerateStrong

Growth Indicators

2025
Revenue Growth
53.41%
Strong
WeakModerateStrong
Net Income Growth
-109.70%
Weak
WeakModerateStrong
EPS Growth
-73.58%
Weak
WeakModerateStrong

Efficiency & Liquidity

2025
Current Ratio
2.80
Strong
WeakModerateStrong
Quick Ratio
2.54
Strong
WeakModerateStrong
Asset Turnover
1.28x
Strong
WeakModerateStrong
Inventory Turnover
2.26x
Weak
WeakModerateStrong

Cash Flow & Resilience

Core fortress metrics for cash-rich balance sheets in high-inflation / tech-volatility regimes

2025
Free Cash Flow Yield
-5.51%
Weak
WeakModerateStrong
EV / Free Cash Flow
-18.88x
Strong
WeakModerateStrong
Net Debt / EBITDA
-0.42x
Strong
WeakModerateStrong
Interest Burden (EBT / EBIT)
1.456
Strong
WeakModerateStrong
Return on Invested Capital
-112.28%
Weak
WeakModerateStrong
Cash Conversion Cycle
56.95 days
Weak
WeakModerateStrong

Fortress screener guardrails

1/4 passing
  • FCF Yield > 3%
  • Net Debt / EBITDA < 1.5x
  • ROIC > 20%
  • Cash Conversion Cycle < 0 days

Financial Statements

Want to see the complete financial picture? View detailed financial statements including income statements, balance sheets, and cash flow statements for MTAC.

View Financial Statements